Trial site
Las Vegas Clinical Trials
North Las Vegas, Nevada 89030, United StatesNot linked to an institution yet
- 9running trials
- 12closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Phase
- Phase 312 trials
- Phase 26 trials
- Phase 1/22 trials
- Phase 41 trial
- Status
- Completed11 trials
- Recruiting6 trials
- Active, not recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Amgen4 trials
- TriGemX Bio, Inc.3 trials
- BioNTech SE2 trials
- Crystalys Therapeutics2 trials
- ModernaTX, Inc.2 trials
- and 7 more
Running trials
Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
NCT07674654· Phase 3· TriGemX Bio, Inc.· Source
Contact: Annemarie Vance
Recruiting
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
NCT07645924· Phase 3· TriGemX Bio, Inc.· Source
Contact: Annemarie Vance
Recruiting
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction to Prevent First Major Cardiovascular Events
NCT07136012· Phase 3· Amgen· Source
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
NCT07089888· Phase 3· Crystalys Therapeutics· Source
Contact: Alton Walters, MD
Recruiting
A Study of Dotinurad Versus Allopurinol in Participants With Gout
NCT07089875· Phase 3· Crystalys Therapeutics· Source
Contact: Alton Walters, MD
Active, not recruiting
53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee
NCT06865079· Phase 2· OrthoTrophix, Inc· Source
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
NCT06226883· Phase 2· Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)· Source
Contact: Christian Stone (principal investigator)
Active, not recruiting
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
NCT06098079· Phase 4· Currax Pharmaceuticals· Source
Active, not recruiting
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension
NCT05968430· Phase 3· Mineralys Therapeutics Inc.· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine
NCT06848075· Phase 2· TriGemX Bio, Inc.· Source
Completed
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
NCT06821061· Phase 1/2· BioNTech SE· Source
Completed
A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis
NCT06224192· Phase 3· Amgen· Source
Completed
A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults
NCT06237049· Phase 2· Pfizer· Source
Completed
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
NCT06178991· Phase 3· BioNTech SE· Source
Completed
A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age
NCT06097273· Phase 3· ModernaTX, Inc.· Source
Terminated
Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria
NCT06077773· Phase 2· Escient Pharmaceuticals, Inc· Source
Completed
Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)
NCT05813275· Phase 3· Apnimed· Source
Completed
A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)
NCT05899816· Phase 3· Amgen· Source
Completed
A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).
NCT05886777· Phase 2· Pfizer· Source
Completed
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults
NCT05827926· Phase 1/2· ModernaTX, Inc.· Source
Completed
A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)
NCT05724199· Phase 3· Amgen· Source
Report an error